The Broken Demand/Supply Model of US Healthcare - How to Fix?

Question

America’s Healthcare Dilemma: The Economics of Unconstrained Demand - by Lance Amundsen LCA13@yahoo.com

America spends more on healthcare than any other industrialized nation—roughly 20% of GDP—yet the outcomes fail to justify the expense. The reason lies in a structural flaw: healthcare operates on an unconstrained demand model fueled by third-party payment systems. Without significant reforms, this model will not only continue to spiral costs but also pose an economic security risk to the nation.

The Problem: A Market Without Constraints

In a typical market, consumers make purchasing decisions with their own money, balancing cost and value. In U.S. healthcare, however, consumers primarily spend “other people’s money”—namely, that of insurance companies, employers, or the government. This disconnect from direct financial responsibility removes the incentive to seek value, driving demand higher and pushing prices upward.

A Starbucks Analogy

Imagine you could buy as much coffee as you wanted with only a 15-cent copay. Would you consider the cost of a $6 latte? Probably not. Soon, demand for premium coffee would skyrocket, and Starbucks might even charge $10 or $100 to meet growing expectations. This is precisely how U.S. healthcare operates: with unconstrained demand driving both excessive supply and inflated prices.

Insurance Companies: The Only Governor

In this dysfunctional market, insurance companies emerge as the sole entity attempting to constrain demand. They do so by denying claims, limiting coverage, or raising copays. While unpopular, these actions are the only mechanisms keeping demand—and costs—from becoming even more untenable.

Why Costs Keep Rising

Despite insurance companies’ interventions, healthcare costs in the U.S. remain disproportionately high compared to other nations. Administrative inefficiencies, high drug prices, and unregulated service pricing amplify the problem. A report from the Commonwealth Fund found that the U.S. spends nearly twice as much per capita on healthcare as other developed nations like Germany or Canada, without better outcomes.

Lessons from Single-Payer Systems

Countries with single-payer systems manage costs through mechanisms like budget caps, negotiated prices, and rationing care. These approaches create constraints on both supply and demand, leading to more sustainable healthcare spending. For example, the UK’s National Health Service operates with a fixed budget, forcing prioritization of essential services over elective ones.

The Unchecked Role of Suppliers

In the U.S., suppliers (hospitals, pharmaceutical companies, and device manufacturers) operate without significant price constraints. They capitalize on the lack of demand limitations, charging higher prices simply because they can. A RAND Corporation study found that U.S. hospitals charge private insurers 247% more than what Medicare pays for the same services.

The Economic Consequences

Healthcare costs aren’t just a personal burden—they’re a national one. With healthcare encompassing one-fifth of the economy, any disruption to the system, whether through cyberattacks or economic crises, could have catastrophic consequences. The American Enterprise Institute has warned of the systemic risks posed by an over-reliant healthcare sector.

A Call for Systemic Reform

Fixing this issue requires addressing the root causes. Encouraging price transparency, limiting third-party payment systems, and introducing value-based care models are potential solutions. Policymakers should also explore adopting supply-side constraints or hybrid models that incorporate elements of single-payer systems while preserving market competition.

Citing Thought Leaders

This analysis aligns with perspectives shared by prominent economists and healthcare experts:
    •    Milton Friedman, in his critique of third-party payment systems, emphasized how they distort the healthcare market.
    •    Dr. Atul Gawande, in his essay The Cost Conundrum, highlighted how regional spending disparities arise from unchecked supplier incentives.
    •    Elizabeth Rosenthal, author of An American Sickness, detailed how profit motives inflate costs across the system.

Consumer Behavior Must Change

Ultimately, consumers must have “skin in the game” to curb excessive demand. High-deductible health plans and health savings accounts (HSAs) are steps in the right direction, as they make individuals more aware of the true cost of care. However, these measures must be paired with broader systemic changes to be effective.

Insurance Companies: Villains or Unsung Heroes?

While insurance companies often bear public ire for denying coverage, their role as demand governors is essential under the current model. Without them, costs would rise even faster, and healthcare spending would further crowd out other vital sectors like education and infrastructure.

The Global Comparison

Countries like Switzerland and Singapore offer alternative models worth studying. Both balance public and private contributions while enforcing cost control mechanisms that prevent runaway expenses. Singapore’s use of mandatory medical savings accounts combined with catastrophic coverage is particularly notable.

The Cost of Inaction

Failing to reform the system will have dire consequences. As healthcare spending continues to outpace GDP growth, it will exert greater pressure on government budgets, private employers, and individual households. The Congressional Budget Office projects that by 2030, federal healthcare spending alone will consume 30% of GDP.

A Security Risk We Can’t Ignore

The economic risks posed by the healthcare sector are not merely financial but also strategic. As cyber threats grow, targeting an industry that constitutes a fifth of the economy could destabilize the entire country. The U.S. cannot afford to ignore this vulnerability.

What Needs to Change

Reforms must focus on aligning incentives across all stakeholders—patients, providers, and insurers. Transparency in pricing, caps on excessive profits, and a shift to value-based care can help create a more balanced system. Policymakers must prioritize these changes to safeguard the nation’s economic and physical health.

Conclusion: A Broken System Requires Bold Action

America’s healthcare system is as broken as it can be. But the solutions are within reach if we are willing to learn from other nations and rethink entrenched practices. The stakes are too high—economically, socially, and strategically—to maintain the status quo.

Answer 1

Author Update — May 2026: Correction and Qualification to This Healthcare Economics Post

Note: I had a healthy debate with AI on this subject and this is ChatGPT's resulting position.  My point is that this is an AI answer but largely influenced by long conversation.
----------------------------------------
This was an early exploratory post. The central concern remains worth examining, but several factual statements and some of the original wording require correction.

First, the current spending figure should be corrected. U.S. healthcare spending remains exceptionally high, but it is not accurately stated here as 20% of GDP. According to the Centers for Medicare & Medicaid Services, national health expenditures reached $5.3 trillion in 2024, representing 18.0% of GDP.

Second, the original post stated its causal argument too categorically. Comparative evidence indicates that the United States spends far more on healthcare than peer wealthy countries primarily because it pays much higher prices for medical services and products, not because Americans simply consume proportionally more healthcare.

That observation does not eliminate the structural concern raised in this post. It sharpens it.

The deeper question is why unusually high prices are sustainable in the United States. My argument is that third-party payment is one important part of that answer. When consumers are insulated from most of the direct price of care, ordinary demand-side price discipline is weakened. Just as importantly, the system has less reason to generate usable price-and-quality information for consumers, because patients are often not functioning as the active economic purchasers of the care they receive.

In that sense, price opacity is not merely an unrelated flaw. It may be partly endogenous to the payment structure itself. When consumers do not routinely choose among providers on the basis of price and quality, suppliers have less incentive to present medical care in a form that enables meaningful value comparison.

This does not mean that higher prices are explained only by third-party payment. The U.S. healthcare system also contains provider consolidation, non-transparent pricing, fragmented purchasing, administrative complexity, pharmaceutical-pricing structures, asymmetric information, and categories of care that patients cannot realistically shop at the moment of need.

The more defensible present claim is therefore:

Third-party payment is a major structural contributor to weakened price discipline in U.S. healthcare, operating alongside supplier market power, institutional complexity, and limited competition in many medical markets.

Third, the Starbucks analogy in the original post should be read narrowly. It illustrates the incentive problem created when consumers receive services while bearing only a small fraction of the visible price. It does not adequately model healthcare as a whole. Emergency treatment, complex illness, clinician-directed care, hospital concentration, and insurance risk pooling make healthcare fundamentally different from ordinary discretionary purchases.

Fourth, the RAND Health Insurance Experiment should also be interpreted carefully. RAND found that exposing consumers to more cost sharing reduced their use of healthcare, but reduced highly effective and less-effective care in roughly equal proportions. That finding is a serious warning against the simple prescription that higher deductibles or copays, by themselves, will selectively remove waste.

However, RAND did not test the broader institutional reform suggested by my underlying argument. It did not test a healthcare market redesigned around:

- meaningful consumer price responsibility where care is genuinely shoppable;
- transparent and usable price information before treatment;
- comparable quality information;
- provider competition for informed consumer demand;
- better purchasing and network design before emergency need arises; and
- protections or institutional purchasing mechanisms for emergency and non-shoppable care.

The relevant distinction is between merely charging patients more inside the existing information-poor system, and creating a system in which consumers and purchasers have both the incentive and the information needed to choose higher-value care.

Fifth, one statistic in the original post was misstated. The RAND finding was that privately insured patients’ hospital prices averaged approximately 247% of what Medicare would have paid in its 2018 analysis. That is not the same as saying private insurers paid 247% more than Medicare.

Sixth, the statement that the Congressional Budget Office projected federal healthcare spending alone would consume 30% of GDP by 2030 was incorrect and should be withdrawn. Federal healthcare spending is a serious long-term fiscal issue, but that specific claim should not remain in the public record.

Seventh, the original post described insurers as effectively the only governor of healthcare demand. That is also too simple. Insurers do constrain utilization and negotiate some prices, but government payment rules, provider capacity, employer benefit design, clinical decision-making, networks, formularies, regulation, and patient cost exposure all participate in the control structure. Insurers are part of the system, not a complete solution to it.

The underlying concern remains valid: the United States spends far more on healthcare than comparable wealthy countries while achieving weak outcomes on many measures. The original post was right to focus on distorted market discipline, but it overstated that explanation as though it operated alone.

My corrected view is this:

The U.S. healthcare system sustains excessive prices in part because third-party payment weakens ordinary consumer price discipline and suppresses demand for usable price-and-quality comparison. A serious reform agenda would need to restore meaningful value selection where care is shoppable, while also confronting provider concentration, price opacity, administrative fragmentation, drug-pricing structures, and the special problems of emergency and non-shoppable care.

This healthcare-economics post was exploratory and separate from my later PV-PP framework research. It should not be read as a statement of current PV-PP doctrine.